CELLTRION, INC.

Inactive Instrument

Analyst Reco. Celltrion, Inc. Korea S.E.

Equities

068270

KR7068270008

End-of-day quote Korea S.E. Other stock markets
- ^KRW	-

May. 24	Celltrion Receives European Commission Approval of Omlyclo® (CT-P39), the First and Only Omalizumab Biosimilar Approved in Europe	CI
May. 10	Celltrion's Q1 Attributable Profit Slumps 86%	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

South Korean Shares Decline After Latest Fed Minutes Indicate Continuation of High-Interest Rates	Jan. 04	MT
South Korean Shares Close Higher as Investors Look Beyond Further Rate Hike Decision by US Fed; Celltrion Adds 1%	23-08-28	MT
South Korean Shares Decline on Concerns over US Fed Rate Hike, China Economic Turmoil	23-08-18	MT
South Korean shares track Wall Street higher; Fed rate decision in focus	22-12-13	RE
South Korea’s Kospi Gains on US Fed’s Decision to Not Focus on Pace of Rate Hikes	22-02-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer